How are CYP2D6 and allergy related?

The relationship between CYP2D6 and allergies is not well-established in scientific literature. CYP2D6 is a key drug-metabolizing enzyme involved in the breakdown of many medications, including some antihistamines and corticosteroids used for allergies. Some studies have explored whether CYP2D6 genetic variants (phenotypes like poor, intermediate, extensive, or ultrarapid metabolizer) are associated with increased risk of allergic conditions such as asthma or hay fever. However, findings are inconsistent and often not replicated. There is some evidence that CYP2D6 metabolizer status may influence the efficacy or side effects of certain antihistamines, but this is not a standard clinical consideration. Most allergy genetic testing focuses on other genes (e.g., HLA, IL-4, FCER1A). Therefore, the evidence for a direct link between CYP2D6 and allergies is weak to unclear. Consumers should not rely on CYP2D6 genetic tests alone to assess allergy risk or adjust medications. Clinical evaluation by a physician is essential.